Clinical trial
Ciclesonide for the Treatment of Airway Hyperresponsiveness: The Mannitol-Asthma-Ciclesonide-Study
NCT03839433 is registered in ClinicalTrials.gov with Cantonal Hosptal, Baselland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ciclesonide for the Treatment of Airway Hyperresponsiveness: The Mannitol-Asthma-Ciclesonide-Study
- Lead sponsor
- Cantonal Hosptal, Baselland
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- August 31, 2008
- Enrollment
- 72 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
asthma, bronchial